Aspira Women's Health (AWH) Competitors $0.08 -0.01 (-12.49%) As of 04/16/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AWH vs. SNSE, APRE, NEUP, ACXP, PMCB, MYNZ, CELZ, CARM, HCWB, and CHROShould you be buying Aspira Women's Health stock or one of its competitors? The main competitors of Aspira Women's Health include Sensei Biotherapeutics (SNSE), Aprea Therapeutics (APRE), Neuphoria Therapeutics Inc. - Common Stock (NEUP), Acurx Pharmaceuticals (ACXP), PharmaCyte Biotech (PMCB), Mainz Biomed (MYNZ), Creative Medical Technology (CELZ), Carisma Therapeutics (CARM), HCW Biologics (HCWB), and Chromocell Therapeutics (CHRO). These companies are all part of the "pharmaceutical products" industry. Aspira Women's Health vs. Sensei Biotherapeutics Aprea Therapeutics Neuphoria Therapeutics Inc. - Common Stock Acurx Pharmaceuticals PharmaCyte Biotech Mainz Biomed Creative Medical Technology Carisma Therapeutics HCW Biologics Chromocell Therapeutics Aspira Women's Health (NASDAQ:AWH) and Sensei Biotherapeutics (NASDAQ:SNSE) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, community ranking, media sentiment, valuation, dividends, profitability, risk and analyst recommendations. Which has higher valuation and earnings, AWH or SNSE? Aspira Women's Health has higher revenue and earnings than Sensei Biotherapeutics. Sensei Biotherapeutics is trading at a lower price-to-earnings ratio than Aspira Women's Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAspira Women's Health$9.18M0.27-$16.69M-$0.98-0.08Sensei BiotherapeuticsN/AN/A-$34.10M-$1.20-0.33 Does the MarketBeat Community believe in AWH or SNSE? Sensei Biotherapeutics received 16 more outperform votes than Aspira Women's Health when rated by MarketBeat users. Likewise, 81.08% of users gave Sensei Biotherapeutics an outperform vote while only 16.87% of users gave Aspira Women's Health an outperform vote. CompanyUnderperformOutperformAspira Women's HealthOutperform Votes1416.87%Underperform Votes6983.13% Sensei BiotherapeuticsOutperform Votes3081.08% Underperform Votes718.92% Is AWH or SNSE more profitable? Sensei Biotherapeutics has a net margin of 0.00% compared to Aspira Women's Health's net margin of -165.07%. Aspira Women's Health's return on equity of 0.00% beat Sensei Biotherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Aspira Women's Health-165.07% N/A -267.23% Sensei Biotherapeutics N/A -53.86%-46.91% Do institutionals & insiders believe in AWH or SNSE? 12.2% of Aspira Women's Health shares are held by institutional investors. Comparatively, 10.5% of Sensei Biotherapeutics shares are held by institutional investors. 4.3% of Aspira Women's Health shares are held by company insiders. Comparatively, 23.2% of Sensei Biotherapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts recommend AWH or SNSE? Aspira Women's Health presently has a consensus target price of $5.50, suggesting a potential upside of 6,607.32%. Sensei Biotherapeutics has a consensus target price of $4.25, suggesting a potential upside of 970.53%. Given Aspira Women's Health's higher probable upside, equities research analysts plainly believe Aspira Women's Health is more favorable than Sensei Biotherapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aspira Women's Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Sensei Biotherapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to AWH or SNSE? In the previous week, Sensei Biotherapeutics had 1 more articles in the media than Aspira Women's Health. MarketBeat recorded 2 mentions for Sensei Biotherapeutics and 1 mentions for Aspira Women's Health. Aspira Women's Health's average media sentiment score of 1.87 beat Sensei Biotherapeutics' score of 1.44 indicating that Aspira Women's Health is being referred to more favorably in the media. Company Overall Sentiment Aspira Women's Health Very Positive Sensei Biotherapeutics Positive Which has more volatility and risk, AWH or SNSE? Aspira Women's Health has a beta of 2.01, indicating that its stock price is 101% more volatile than the S&P 500. Comparatively, Sensei Biotherapeutics has a beta of 0.21, indicating that its stock price is 79% less volatile than the S&P 500. SummaryAspira Women's Health beats Sensei Biotherapeutics on 9 of the 16 factors compared between the two stocks. Get Aspira Women's Health News Delivered to You Automatically Sign up to receive the latest news and ratings for AWH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AWH vs. The Competition Export to ExcelMetricAspira Women's HealthDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.44M$2.55B$5.51B$7.93BDividend YieldN/A0.75%5.11%4.22%P/E Ratio-0.077.6222.5518.49Price / Sales0.2750.05394.97102.66Price / CashN/A15.7538.1834.62Price / Book-0.363.746.694.25Net Income-$16.69M-$65.73M$3.22B$248.31M7 Day PerformanceN/A0.29%1.11%1.12%1 Month PerformanceN/A-2.05%3.59%3.68%1 Year PerformanceN/A-10.80%15.65%5.19% Aspira Women's Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AWHAspira Women's Health2.3281 of 5 stars$0.08-12.5%$5.50+6,607.3%-97.5%$2.44M$9.18M-0.07110Positive NewsHigh Trading VolumeSNSESensei Biotherapeutics4.6445 of 5 stars$0.39-4.7%$4.25+1,001.9%-60.1%$9.72MN/A-0.3240Upcoming EarningsPositive NewsGap DownAPREAprea Therapeutics3.2866 of 5 stars$1.75+10.1%$15.50+785.7%-65.9%$9.61M$580,000.00-0.627Gap UpHigh Trading VolumeNEUPNeuphoria Therapeutics Inc. - Common Stock1.9436 of 5 stars$5.39+6.9%$21.00+289.6%N/A$9.47M$662,715.000.00N/APositive NewsACXPAcurx Pharmaceuticals2.6765 of 5 stars$0.42+3.6%$12.00+2,764.0%-80.9%$9.39MN/A-0.383News CoveragePositive NewsPMCBPharmaCyte Biotech1.626 of 5 stars$1.29+5.7%N/A-41.5%$8.86MN/A2.434Gap UpMYNZMainz Biomed2.9792 of 5 stars$3.70+4.8%$14.00+278.4%-90.3%$8.58M$893,991.00-0.0630Short Interest ↓Gap UpHigh Trading VolumeCELZCreative Medical Technology1.1999 of 5 stars$1.95-1.0%N/A-53.4%$8.55M$11,000.00-0.515Positive NewsCARMCarisma Therapeutics3.4427 of 5 stars$0.20-9.7%$1.93+843.6%-87.8%$8.53M$19.63M-0.1320Upcoming EarningsShort Interest ↓Positive NewsHCWBHCW Biologics1.0035 of 5 stars$7.58+9.8%N/A-85.6%$8.51M$2.57M-7.5840Gap DownCHROChromocell TherapeuticsN/A$1.35-0.7%N/A-36.3%$8.24MN/A-0.924Gap Down Related Companies and Tools Related Companies SNSE Alternatives APRE Alternatives NEUP Alternatives ACXP Alternatives PMCB Alternatives MYNZ Alternatives CELZ Alternatives CARM Alternatives HCWB Alternatives CHRO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AWH) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aspira Women's Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aspira Women's Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AWH Stock Free AWH Stock Alerts